Marksans Pharma Limited
NSE:MARKSANS.NS
300.5 (INR) • At close November 12, 2024
Overview | Financials
Cijfers zijn in miljoenen (behalve de cijfers per aandeel en de ratio's) INR.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operationele Activiteiten: | ||||||||||||||||||
| Nettowinst
| 3,137 | 3,376.53 | 2,475.11 | 3,021.641 | 1,571.718 | 1,043.066 | 497.981 | 155.293 | 1,068.507 | 1,093.965 | 719.077 | 458.843 | -1,788.397 | -2,232.444 | -100.434 | -83.554 | 154.183 | 67.862 |
| Afschrijvingen & Amortisatie
| 742.7 | 518.53 | 447.76 | 361.514 | 266.615 | 228.039 | 268.383 | 300.93 | 281.27 | 161.34 | 156.912 | 156.499 | 0.131 | 199.752 | 154.745 | 153.545 | 92.851 | 73.266 |
| Uitgestelde Inkomstenbelasting
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Aandelen Gebaseerde Vergoedingen
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Verandering in Werkkapitaal
| -1,261.92 | -1,114.65 | -1,107.02 | -1,500.278 | 357.336 | -817.92 | -273.958 | -240.995 | -841.644 | 208.522 | -260.103 | -261.062 | -80.575 | 404.956 | -46.344 | 45.246 | -46.568 | -492.306 |
| Vorderingen
| -371.67 | -275.18 | -1,039.34 | -367.44 | -667.548 | 3.086 | 706.756 | -302.882 | -338.386 | -138.471 | -382.93 | -185.456 | 0 | 0 | 0 | 0 | 0 | 0 |
| Voorraden
| -1,126.73 | -448.5 | -178.49 | -1,624.758 | 514.021 | -751.22 | -280.372 | -222.952 | -376.85 | -275.18 | -248.968 | -43.33 | -61.407 | 373.043 | 145.574 | 203.528 | -154.978 | -450.273 |
| Crediteuren
| 526.89 | 224.23 | 184.9 | 417.84 | 665.731 | 90.366 | -842.589 | 429.752 | 66.939 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Overig Werkkapitaal
| -290.41 | -615.2 | -74.09 | 74.08 | -154.868 | -160.153 | 6.414 | -18.043 | -464.795 | 483.702 | -11.135 | -217.732 | -19.168 | 31.912 | -191.918 | -158.281 | 108.41 | -42.033 |
| Overige Niet-Contante Posten
| 2,400.15 | -406.29 | -823.28 | -95.467 | -96.234 | -179.235 | 96.797 | -126.804 | -200.128 | 81.305 | 32.505 | 31.324 | 1,245.878 | 896.243 | 161.228 | 84.948 | 31.077 | -9.415 |
| Kasstroom uit Operationele Activiteiten
| 2,561.02 | 2,374.12 | 992.57 | 1,787.409 | 2,099.434 | 273.95 | 589.203 | 88.424 | 308.005 | 1,545.132 | 648.39 | 385.603 | -622.964 | -731.494 | 169.195 | 200.186 | 231.544 | -360.593 |
| Investeringsactiviteiten: | ||||||||||||||||||
| Investeringen in Materiële Vaste Activa
| -2,088.38 | -536.31 | -463.3 | -464.24 | -596.266 | -131.465 | -389.351 | -277.489 | -1,318.748 | -364.656 | -52.08 | 0 | -52.797 | 129.381 | -268.698 | -1,256.818 | -1,398.271 | -222.723 |
| Netto Overnames
| 8.54 | -266.1 | 0.34 | 5.2 | 2.82 | 0 | 0 | 0 | 0 | 0 | -52.08 | -64.254 | 0 | 0 | 0 | 0 | 0 | 0 |
| Aankoop van Beleggingen
| -370.01 | -1,897.66 | -1.5 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 100 | -100 | 0 | 0 | 0.05 |
| Verkoop/verval van Beleggingen
| 732.78 | 2,163.76 | -0.34 | 0 | 0 | 0.952 | 0.499 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Overige Investeringsactiviteiten
| 679.98 | -2,055.81 | 47.94 | 10.081 | -1.854 | -4.282 | 1.559 | 69.053 | 88.63 | 32.762 | 7.2 | 9.973 | 20.254 | 16.729 | 15.438 | 76.357 | 57.355 | 95.469 |
| Kasstroom uit Investeringsactiviteiten
| -1,717.07 | -2,592.12 | -416.86 | -448.959 | -595.299 | -134.796 | -387.792 | -208.436 | -1,230.118 | -331.893 | -44.88 | -54.282 | -32.543 | 246.11 | -353.259 | -1,180.461 | -1,340.917 | -127.204 |
| Financieringsactiviteiten: | ||||||||||||||||||
| Schuldaflossingen
| -124.97 | 52.96 | 225.52 | -1.03 | -810.662 | -66.776 | 170.683 | 218.535 | -334.974 | -998.675 | -84.646 | -2,351.19 | -112.292 | 527.192 | 274.905 | 558.054 | 191.561 | 148.548 |
| Uitgifte van Gewone Aandelen
| 0 | 2,747.09 | 911.55 | 0 | 703.047 | 0 | 0 | 0 | 0 | 1,312.435 | 0 | 44.8 | 11.566 | 0.045 | -2.152 | 171.165 | 0 | 0 |
| Terugkoop van Gewone Aandelen
| 0 | -451.66 | 0 | 0 | -50 | 0 | -10 | -15 | 0 | -10 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Uitgekeerde Dividenden
| -226.58 | -101.71 | -105.83 | -40.93 | -295.032 | -44.441 | -24.632 | -145.302 | -179.608 | -69.716 | -104.236 | -46.79 | -2.692 | 0 | 0 | -5.457 | 0 | 0 |
| Overige Financieringsactiviteiten
| -284 | -318.39 | -236.13 | -110.89 | 57.615 | -96.554 | -112.203 | -29.395 | -62.945 | -74.101 | -103.957 | 1,956.792 | 685.143 | -87.647 | 164.743 | -135.931 | -53.21 | -49.918 |
| Kasstroom uit Financieringsactiviteiten
| -635.55 | 1,978.29 | 795.11 | -152.859 | -901.478 | -207.772 | -54.263 | 18.62 | -577.526 | 169.943 | -292.839 | -396.388 | 570.159 | 439.59 | 315.633 | 587.832 | 138.35 | 98.63 |
| Overige Informatie: | ||||||||||||||||||
| Effect van Wisselkoersveranderingen op Kas
| 0 | 0.02 | -1,428.59 | -1.032 | 6.064 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -0 |
| Netto Kasstroomverandering
| 2,907.22 | 1,760.31 | 1,370.82 | 1,185.591 | 602.657 | -68.617 | 147.147 | -101.392 | -1,499.639 | 1,383.182 | 310.67 | -65.066 | -85.348 | -45.794 | 131.569 | -392.443 | -971.023 | -389.167 |
| Kaspositie aan het Einde van de Periode
| 6,735.77 | 3,824.37 | 3,492.65 | 2,122.862 | 931.207 | 328.55 | 398.769 | 251.621 | 353.013 | 1,852.652 | 469.47 | 158.8 | 223.866 | 309.214 | 355.007 | 223.438 | 615.881 | 1,586.904 |